Severe Diarrhea; Kidney pain; severe debilitating headache; severe abdominal pain (gastrointestinal, uterine, ovarian, and vaginal); severe abdominal pain (gastrointestinal, uterine, ovarian, and vaginal); severe abdominal pain (gastrointestinal, uterine, ovarian, and vaginal); severe abdominal pain (gastrointestinal, uterine, ovarian, and vaginal); severe abdominal pain (gastrointestinal, uterine, ovarian, and vaginal); Fever 100.5 degree F; severe joint pain; severe lower back pain; chills; vomiting bile; no appetite; fatigue; muscle and body aches; muscle and body aches; sharp rib pain; chest & diaphragm pain; chest & diaphragm pain; shortness of breath; had me Crying; I wasn't asleep; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 01May2021 12:00 (Lot number: Ek8735) at the age of 28 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Fibromyalgia" (unspecified if ongoing); "PCOS" (unspecified if ongoing); "Multiple Chemical Sensitivity" (unspecified if ongoing); "PTSD" (unspecified if ongoing); "ASD" (unspecified if ongoing); "if covid prior vaccination Yes" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Ew0153, Location of injection: Arm left, Vaccine Administration Time: 12:00 PM), administration date: 10Apr2021, when the patient was 28 years old, for Covid-19 Immunization. The following information was reported: DIARRHOEA (non-serious) with onset 12Feb2022 20:00, outcome "recovering", described as "Severe Diarrhea"; RENAL PAIN (non-serious) with onset 12Feb2022 20:00, outcome "recovering", described as "Kidney pain"; HEADACHE (non-serious) with onset 12Feb2022 20:00, outcome "recovering", described as "severe debilitating headache"; ABDOMINAL PAIN (non-serious), GASTROINTESTINAL PAIN (non-serious), UTERINE PAIN (non-serious), ADNEXA UTERI PAIN (non-serious), VULVOVAGINAL PAIN (non-serious) all with onset 12Feb2022 20:00, outcome "recovering" and all described as "severe abdominal pain (gastrointestinal, uterine, ovarian, and vaginal)"; PYREXIA (non-serious) with onset 12Feb2022 20:00, outcome "recovering", described as "Fever 100.5 degree F"; ARTHRALGIA (non-serious) with onset 12Feb2022 20:00, outcome "recovering", described as "severe joint pain"; BACK PAIN (non-serious) with onset 12Feb2022 20:00, outcome "recovering", described as "severe lower back pain"; CHILLS (non-serious) with onset 12Feb2022 20:00, outcome "recovering", described as "chills"; VOMITING (non-serious) with onset 12Feb2022 20:00, outcome "recovering", described as "vomiting bile"; DECREASED APPETITE (non-serious) with onset 12Feb2022 20:00, outcome "recovering", described as "no appetite"; FATIGUE (non-serious) with onset 12Feb2022 20:00, outcome "recovering", described as "fatigue"; MYALGIA (non-serious), PAIN (non-serious) all with onset 12Feb2022 20:00, outcome "recovering" and all described as "muscle and body aches"; MUSCULOSKELETAL CHEST PAIN (non-serious) with onset 12Feb2022 20:00, outcome "recovering", described as "sharp rib pain"; CHEST PAIN (non-serious), DIAPHRAGMATIC DISORDER (non-serious) all with onset 12Feb2022 20:00, outcome "recovering" and all described as "chest & diaphragm pain"; DYSPNOEA (non-serious) with onset 12Feb2022 20:00, outcome "recovering", described as "shortness of breath"; CRYING (non-serious) with onset 12Feb2022 20:00, outcome "recovering", described as "had me Crying"; INSOMNIA (non-serious) with onset 12Feb2022 20:00, outcome "recovering", described as "I wasn't asleep". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of diarrhoea, renal pain, headache, abdominal pain, gastrointestinal pain, uterine pain, adnexa uteri pain, vulvovaginal pain, pyrexia, arthralgia, back pain, chills, vomiting, decreased appetite, fatigue, myalgia, pain, musculoskeletal chest pain, chest pain, diaphragmatic disorder, dyspnoea, crying, insomnia.  Additional information: No other vaccine in four weeks. None other medications in two weeks. Patient would have gone to the emergency room, if patient had health coverage. Not tested COVID post vaccination. Known allergies: None known but diagnosed with Multiple Chemical Sensitivity. Other vaccine same date details: product= Pfizer, lot number=Fk9896, vaccine date=19Feb2022, dose number=3, vaccine location=Right arm.  Follow-up attempts are completed. No further information is expected.